Form 4: NeueHealth CFO Jay Matushak Reports Stock Unit Vesting
SEC Form 4 Filing
Chief Financial Officer of NeueHealth, Jay Matushak, reports the vesting of restricted stock units.
Summary
- On May 9, 2025, Jay Matushak, the Chief Financial Officer of NeueHealth, Inc., had 978 restricted stock units vest.
- These units convert into 978 shares of NeueHealth's common stock.
- Following the transaction, Matushak directly owns 41,028 shares of common stock.
- The restricted stock units vested over three years, with one-third vesting each year on May 9, 2023, May 9, 2024, and May 9, 2025.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and doesn't indicate any significant positive or negative sentiment.
Positives
- The vesting of restricted stock units aligns the CFO's interests with those of the shareholders.
Future Outlook
NA
Industry Context
This is a standard SEC Form 4 filing, reporting a change in beneficial ownership due to the vesting of restricted stock units, a common form of executive compensation.
Stakeholder Impact
- The vesting of stock units aligns management's interests with shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/09/2023 | One-third of the restricted stock units vested. |
| 05/09/2024 | One-third of the restricted stock units vested. |
| 05/09/2025 | Final one-third of the restricted stock units vested; transaction date. |
| 05/13/2025 | Date of Form 4 filing. |
Keywords
NeueHealth, Matushak, Restricted Stock Units, CFO, Vesting, NEUE, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.